Traditionally, pharma has engaged with stakeholders during physical meetings to seek input. In today’s environment, however, healthcare providers are less and less inclined to travel across the globe for a 1- or 2-day meeting. This puts pharma companies under pressure, as they continue to have a need for insights into treatment patterns, and filling meetings […]

At Aptitude Health, the daily project portfolio for the Medical Publications team is extremely diverse but boils down to one thing: Effectively communicating the clinical relevance of our clients’ products. Such communication requires well-researched content that is of high quality, accurate, and up to date with the newest medical developments. With all the available articles, […]

For pharma reps, there is a historic battle to gain access to targeted physicians. And with a growing number of patient appointments packed into each day, reps can expect even stiffer waiting room competition and tighter restrictions on physician access.

Along with numerous networking opportunities, the takeaways regarding industry trends, innovations, discoveries, and advancements are the major benefits of attending an oncology conference. But often, due to the grandiosity of such events, it’s difficult to walk away feeling like you’ve experienced everything you had planned.

Medical communications agencies generate reports on oncology insights derived from a variety of industry-sponsored activities. Often these activities are on 1 particular company or product, which leads to discussions focusing on 1 specific topic. But insights reports can also range in scope and provide a look at the current oncology landscape from a broader perspective. […]

This blog will identify some of the innovative as well as conventional ways you can better engage with conference attendees—including key opinion leaders (KOLs)—by delivering dynamic content during live events.

Today there is a need for new ways to bring physicians and pharmaceutical companies together. One of the most important questions to be answered for the pharmaceutical industry is the “why” behind doctors’ treatment decisions, yet this question is becoming increasingly difficult to answer.

Advances in oncology have revolutionized cancer treatments, contributing to improved outcomes for many cancer patients. Nevertheless, major challenges remain, especially in rural and remote communities.